肿瘤综合治疗电子杂志2019，Vol.5Issue(4)：22-27,6.DOI:10.12151/JMCM.2019.04-05
晚期肝细胞癌治疗进展
Recent progresses in the management of advanced hepatocellular carcinoma
摘要
Abstract
Incidence of hepatocellular carcinoma (HCC) is rising worldwide. Previously, drugs approved for the treatment of advanced hepatocellular carcinoma were Sorafenib and Regorafenib. For the past few years, several new agents demonstrated statistically significant improvements in survival in HCC. This review summaries etiologies for HCC and focuses on these progresses in the management of advanced HCC.关键词
肝细胞癌/药物治疗/免疫治疗Key words
Hepatocellular carcinoma/Drug therapy/Immunotherapy引用本文复制引用
曹彦硕,陈学愚..晚期肝细胞癌治疗进展[J].肿瘤综合治疗电子杂志,2019,5(4):22-27,6.基金项目
国家重点研发计划(2017YFC1308900) （2017YFC1308900）
